Hormone therapy and clinical and surrogate cardiovascular endpoints in women with chronic kidney disease: a systematic review and meta-analysis
Conclusions: Studies examining the effect of postmenopausal HT on CV outcomes in women with CKD are lacking. Further prospective study of the role of postmenopausal HT in this high-risk group is required.
Source: Menopause - Category: OBGYN Tags: Review Articles Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Chronic Kidney Disease | Conferences | Databases & Libraries | Heart | Heart Attack | Hormonal Therapy | Hormones | Men | Menopause | OBGYN | Stroke | Study | Urology & Nephrology | Women